0001209191-19-021335.txt : 20190326 0001209191-19-021335.hdr.sgml : 20190326 20190326164349 ACCESSION NUMBER: 0001209191-19-021335 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190322 FILED AS OF DATE: 20190326 DATE AS OF CHANGE: 20190326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Evans David Thomas CENTRAL INDEX KEY: 0001730451 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 19705751 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-22 0 0001666071 Cardlytics, Inc. CDLX 0001730451 Evans David Thomas C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 0 1 0 0 Chief Financial Officer Common Stock 2019-03-22 4 S 0 866 15.65 D 44419 D Common Stock 2019-03-25 4 S 0 887 15.26 D 43532 D Common Stock 2019-03-26 4 S 0 863 15.68 D 42669 D These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2018. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.41 to $15.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.12 to $15.40, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.68 to $15.83, inclusive. /s/ Kirk L. Somers, Attorney-in-Fact 2019-03-26